Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00057447
Status:
TERMINATED
Last Update Posted:
2007-11-01
First Post:
2003-04-01
Brief Title:
Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkins Lymphoma Patients
Sponsor:
InterMune
Organization:
InterMune
Organization Data
Organization:
InterMune
Class:
INDUSTRY
Study ID:
GINHL-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
InterMune
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None